title: Ten years' experience with LSA2-L2 therapy for childhood advanced lymphoblastic lymphoma.
authors.forename: J A
authors.initials: JA
authors.lastname: Katz
authors.forename: E
authors.initials: E
authors.lastname: Hvizdala
authors.forename: J
authors.initials: J
authors.lastname: Shuster
authors.forename: J M
authors.initials: JM
authors.lastname: Falletta
authors.forename: M
authors.initials: M
authors.lastname: Schwenn
authors.forename: S B
authors.initials: SB
authors.lastname: Murphy
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D011241:Prednisone / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone; D008727:Methotrexate; D003630:Daunorubicin